flanked by mink cellular DNA sequences. This DNA fragment was shown to induce focus transformation upon transfection of NIH/ 3T3 mouse cells. Moreover, focus-forming virus could be rescued from transformed nonproducer cells upon superinfection with a type C helper virus. A polyprotein of molecular weight 120,000 (p120) containing murine leukemia virus gag gene determinants was invariably detected by immunoprecipitation analysis of individual transformants induced by the 7.8-kilobase-pair DNA. Molecularly cloned integrated A-MuLV in its infectious form should be ofuse in elucidating the mechanisms involved in transformation by this virus.
Abelson murine leukemia virus (A-MuLV) is a replication-defective transforming mouse type C virus isolated from a lymphoma induced in a prednisolone-treated BALB/c mouse that had been infected with Moloney murine leukemia virus (MMuLV) (1) . Unlike other transforming viruses of mammalian origin that generally induce sarcomas, A-MuLV induces B-cell lymphoid leukemia after inoculation into susceptible murine hosts (2) . In tissue culture, A-MuLV has been shown to transform both lymphoid cells (3, 4) and fibroblasts (5) . By heteroduplex analysis, the A-MuLV genome has been shown to possess sequences homologous to MuLV at its 5' and 3' ends with a unique region of about 3.5 kilobase pairs (kbp) in the center of the molecule (6) . Thus, this virus, like a number ofother replication-defective transforming viruses, appears to represent a genetic recombinant between a helper leukemia virus and cellular DNA. In an effort to elucidate the mechanism of transformation by A-MuLV, we have attempted to amplify its integrated proviral sequences by taking advantage ofrecombinant DNA technology to clone a given segment of the mammalian genome (7) . We report here the detection, isolation, molecular cloning, and initial characterization of integrated proviral DNA derived from DNA of cells nonproductively transformed by A-MuLV. Enrichment of A-MuLV Proviral Sequences from Restriction Endonuclease-Cleaved Cellular DNA. High molecular weight DNA was extracted from frozen cell pellets with phenol! m-cresol as described by Tiemeier et al. (10) . DNA was digested with EcoRI, extracted with phenol, and precipitated with ethanol. Ten milligrams of EcoRI-digested DNA was chromatographed on an RPC-5 column (0.8 x 90 cm) as described (11) . The fractionated DNAs were electrophoresed, transferred to nitrocellulose filters according to the method of Southern (12) , and hybridized to M-MuLV cDNA. 32P-Labeled M-MuLV cDNA was synthesized by using avian myeloblastosis virus DNA polymerase (reverse transcriptase) (13) and RNA purified from M-MuLV. Fractions that hybridized to the M-MuLV cDNA probe were pooled and applied to a 1% preparative agarose gel and fractionated as described (14) . Fractions that hybridized to M-MuLV cDNA were used for molecular cloning.
MATERIALS AND METHODS
Molecular Cloning and Identification of A-MuLV Proviral Recombinant Phage. The EK2 certified vector AgtWES-AB and host Escherichia coli DP5OsupF and E. coli strain LE392 were generously provided by J. G. Seidman and L. Enquist (National Institutes of Health). Purification of AgtWES-AB arms was performed after digestion of DNA with EcoRI as described by Maniatis et The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 Restriction Endonuclease Mapping. Recombinant phage DNA was prepared as described (18) . DNA inserts containing proviral sequences were separated from AgtWESAB arms by EcoRI digestion and preparative agarose gel electrophoresis. Restriction endonuclease mapping of insert was carried out by both double digestion analysis and the partial digestion method of Smith and Birnstiel (19) .
Transfection with Molecularly Cloned A-MuLV Proviral DNA. Transfections were carried out by the calcium precipitation method of Graham and van der Eb (20) as described (21) . NIH/3T3 cells were used as recipients in the transfection assay. Foci were scored at 2-3 weeks. For analysis of virus rescue, individual foci induced at limiting dilution were picked by the cloning cylinder technique and grown up to mass culture, and supernatants were analyzed for A-MuLV focus formation on NIH/3T3 cells after superinfection with M-MuLV as described (22) .
Immunoprecipitation Assays. Antisera. Goat anti-MuLV p15, p12, and p30 sera were obtained from the Resources and Logistics Program of the National Cancer Institutes. Cell labeling and immunoprecipitation. Exponentially growing cultures were labeled with [35S]methionine (560 Ci/mmol) at 0.05 mCi/ml (1 Ci = 3.7 X 1010 becquerels) for 3 hr in Dulbecco's modified Eagle's medium lacking unlabeled methionine. Radiolabeled cells were typed and immunoprecipitated as described (23) . Immunoprecipitates were analyzed by linear 6-12% polyacrylamide gels as reported (23) . (Fig. 2) . From the location ofthe two LTRs, it was determined that proviral DNA was flanked by 1. 8-and a 0.2-kbp of mink cellular sequences at the 5' end and 3' ends, respectively (Fig. 2) .
RESULTS

Enrichment of Cellular
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Biochemistry: Srinivasan et al. 2080 Biochemistry: Srinivasan et al. helper virus. To examine whether transformants induced by the 7.8-kbp DNA fragment contained rescuable A-MuLV, we isolated individual foci induced at limiting DNA dilution. None of the transformants released detectable virus as measured by reverse transcriptase assay of 50-fold concentrates oftissue culture fluids. However, after superinfection with either M-MuLV or R-MuLV, high-titered focus-forming activity ranging from 104.0 to 105.0 focus-forming units/ml was released from all tested transformants (Table 1) .
A-MuLV Expression by Cloned DNA Transformants. AMuLV has been shown to code for expression of a Mr 120,000 protein (p120), which contains MuLV gag gene products p15, p12, and a small-portion of p30, as well as a region-unrelated to known MuLV proteins (2) . The latter is presumed to be encoded by the cell-derived insertion sequence of A-MuLV (2). We examined transformants induced by the 7.8-kbp cloned DNA fragment for expression of MuLV-related gene products by immunoprecipitation analysis. As shown in Fig. 3 (Fig.  3) . These results established that p120 expression is associated with transformation by cloned integrated A-MuLV DNA. DISCUSSION A-MuLV is the only known mammalian transforming oncovirus with a specificity for transformation oflymphoid cells. Thus, this virus system offers a unique opportunity to study the effects of a transforming virus on a differentiating mammalian cell population. The advent of.molecular cloning techniques has recently made it possible to amplify the unintegrated and integrated-proviruses of RNA tumor viruses and to more readily investigate the structure and functions of their transforming genes at a molecular level (18, 25, 26) . In the present report, we have utilized these.techniques to purify and amplify the integrated A-MuLV provirus. A 7.8-kbp DNA EcoRI restriction -fragment cloned from .A-MuLV-transformed mink cells was shown to code for a Mr 120,000 protein containing MuLV.gag gene determinants and presumed to be the A-MuLV transforming gene product (27, 28) . Moreover, the cloned'DNA was found to possess the ability to transform cells in tissue culture.
The strategy for enrichment of proviral sequences by sequential RPC-5 and agarose gel electrophoresis was similar to that previously utilized for cloning of mouse globin and immunoglobulin genes (7, 10, 11) as well as the integrated Moloney murine sarcoma virus genome (25) . The demonstration that approximately 1 out of 6000 plaques contained A-MuLV DNA indicates an enrichment ofproviral sequences by a factor of 200-fold over their unique sequence representation within the cellular DNA ofthe A-MuLV transformant from which these sequences were cloned. Both 10.2-and 11.0-kbp DNA fragments, which were also detected by hybridization with MuLV cDNA in this transformant, were molecularly cloned as well. However, these. molecules lacked restriction sites that identi-fied A-MuLV within them and also failed to demonstrate biologic activity by transfection analysis. Thus, the origin of the 10.2-and 11.0-kbp DNA fragments remains to be determined.
Restriction endonuclease mapping of the biologically active 7.8-kbp DNA fragment revealed several structural features of the cloned integrated A-MuLV provirus. Identification ofa constellation of restriction sites, known to exist within the LTR of M-MuLV (24) , established the presence of and localization of these structures within this DNA fragment. By comparison of the restriction maps of the 7.8-kbp DNA fragment containing integrated A-MuLV genome with that of M-MuLV, we established that the 5.8-kbp A-MuLV genome contained at least 1.15 kbp of M-MuLV sequences at its 5' end and 0.75 kbp at its 3' end. Moreover, approximately 3.6 kbp in the center of the AMuLV provirus were completely dissimilar from MuLV by restriction mapping. These findings argue strongly that the central portion of the A-MuLV genome contains its cellular insertion sequence, an observation consistent with that obtained from heteroduplex analysis of A-MuLV RNA and M-MuLV cDNA (6) . The remaining sequences adjacent to the A-MuLV genome within the 7.8-kbp DNA fragment must represent flanking mink cellular information cloned along with the integrated provirus.
The transforming activity of the integrated A-MuLV genome in transfection studies was comparable to that reported for integrated DNA of murine sarcoma virus (29) . Of note, infectious A-MuLV was rescued at high efficiency by superinfection with helper leukemia virus from each DNA transformant analyzed. In contrast, we have found that transformants induced by a permuted form of the unintegrated murine sarcoma virus genome are most frequently not virus rescuable (unpublished observations). This molecule contains an intact transforming region, but its LTRs are located in tandem in the middle of the molecule. Thus, structural integrity of the linear provirus with LTRs at its termini may be necessary for efficient virus rescue.
A-MuLV induces lymphosarcomas in vivo but transforms fibroblasts as well as lymphoid cells in vitro (2) . There is accumulating evidence that p120, its putative transforming gene product, contains a protein kinase activity that specifically phosphorylates tyrosine residues (30) . Normal thymocytes have been shown to express a protein that is immunologically crossreactive with the A-MuLV p120 and to exhibit protein kinase activity as well (2) . It is not yet known whether the specificity for transformation of different target cells by A-MuLV is mediated by the same or different virus-coded gene products. The cloning of A-MuLV proviral DNA in its infectious form makes it feasible to utilize site-specific mutagenesis (31) in an effort to generate conditional lethal virus mutants. Such studies may help to establish the important functional domains of the AMuLV transforming gene product(s) and to determine whether fibroblastic and lymphoid cell transforming functions reside in the same or different virus-coded genes.
Note Added in Proof. Goffet al. (32) have recently reported the cloning of permuted forms of the unintegrated A-MuLV genome.
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